Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis-Reference-Cited by-同舟云学术

Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis

Published:2022-11 Issue: Volume:Volume 15 Page:6839-6852
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Sidamo Temesgen^ORCID,Rao Prakruti S,Aklillu Eleni^ORCID,Shibeshi Workineh,Park Yumi,Cho Yong-soon,Shin Jae-Gook,Heysell Scott K,Mpagama Stellah G,Engidawork Ephrem^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference57 articles.

1. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

2. World Health Organization. Rapid communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/ RR-TB); 2018.

3. Sterilizing Activities of Fluoroquinolones against Rifampin-Tolerant Populations of Mycobacterium tuberculosis

4. Bactericidal Activity of Increasing Daily and Weekly Doses of Moxifloxacin in Murine Tuberculosis

5. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing;Clinical Microbiology Reviews;2024-06-13

2. Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis;Antimicrobial Agents and Chemotherapy;2024-05-02